De Novo device
Portable Neuromodulation Stimulator (PoNS)
Helius Medical, Inc. · Electrical Tongue Stimulator To Treat Motor Deficits (QCF, Class II) · First FDA decision Mar 26, 2021, newest May 13, 2026Traumatic brain injury and concussion
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
Breakthrough-designated
Device trials
45
Naming "Portable Neuromodulation"
MAUDE reports
0
Brand "Portable Neuromodulation", since 2015
PubMed studies
12
Mentioning "Portable Neuromodulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Portable Neuromodulation Stimulator (PoNS)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Portable Neuromodulation Stimulator (PoNS)Breakthrough510(k)
K253061 · Decided May 13, 2026 · 233 days after receipt
Device type: Electrical Tongue Stimulator To Treat Motor Deficits (QCF) · Neurology & Neurosurgery
- Portable Neuromodulation Stimulator (PoNS)New device typeBreakthroughDe Novo
DEN200050 · Decided Mar 26, 2021 · 234 days after receipt
Device type: Electrical Tongue Stimulator To Treat Motor Deficits (QCF) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Treatment of Motor Function Disorders with Electric Nerve StimulationNational determinationOn the books160.2Updated Aug 17, 2023
- Electrical Aversion Therapy for Treatment of AlcoholismNational determinationOn the books130.4Updated Jun 10, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
- Home Health-Surface Electrical Stimulation in the Treatment of DysphagiaLocal determinationIn effectL34565Palmetto GBAUpdated Nov 21, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Portable Neuromodulation", any status and sponsor, newest update first.
- Trial of Self-Applied Transcutaneous Auricular Vagus Nerve Stimulation for Chemotherapy-Induced Peripheral NeuropathyNot yet recruiting
University of MiamiAcademic, hospital or other
NCT07925580 · 55 participants (planned) · Start Jan 2027 · Primary completion Jun 30, 2029
Device: Sparrow Link (taVNS) · For: Chemotherapy Induced Peripheral Neuropathy (CIPN)
Sites: Miami, Florida
- Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive BladderRecruiting
SEZGINGovernment (non-federal)
NCT07540273 · 60 participants (planned) · Start Aug 15, 2026 · Primary completion Dec 15, 2026
Device: Ambulatory Transcutaneous Tibial Nerve Stimulation; Conventional Clinic-Based Transcutaneous Tibial Nerve Stimulation · For: Overactive Bladder (OAB); Urinary Urgency
Sites: Istanbul, Turkey (Türkiye)
Hospitales NisaAcademic, hospital or other
NCT07817316 · 30 participants (planned) · Start Jun 26, 2026 · Primary completion Oct 1, 2027
Device: verum tRNS + Neurofeedback; sham tRNS + Neurofeedback · For: Acquired Brain Injury Including Stroke; TBI; Stroke and 1 more
Sites: Valencia, Spain
42 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Portable Neuromodulation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QCF
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Portable Neuromodulation"[tiab]. The summary above synthesizes these.
- ALSUntangled #75: Portable neuromodulation stimulator therapy.
Officer L, Armon C, Barkhaus P, et al. · Amyotroph Lateral Scler Frontotemporal Degener · 2024Review, Research Support, Non-U.S. Gov't
- Cranial Nerve Noninvasive Neuromodulation in Adults With Neurological Conditions: Protocol for a Scoping Review.
Boughen K, Neil T, Dullemond S, et al. · JMIR Res Protoc · 2021
- Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de débarquement syndrome.
Cha YH, Gleghorn D, Doudican BC · PLoS One · 2022Randomized Controlled Trial, Research Support, N.I.H., Extramural
- Portable neuromodulation induces neuroplasticity to re-activate motor function recovery from brain injury: a high-density MEG case study.
D'Arcy RCN, Greene T, Greene D, et al. · J Neuroeng Rehabil · 2020Case Reports, Research Support, Non-U.S. Gov't
- Translingual Neurostimulation for the Treatment of Chronic Symptoms Due to Mild-to-Moderate Traumatic Brain Injury.
Tyler M, Skinner K, Prabhakaran V, et al. · Arch Rehabil Res Clin Transl · 2019
- Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study.
Leonard G, Lapierre Y, Chen JK, et al. · Mult Scler J Exp Transl Clin · 2017
- Feasibility of sensory tongue stimulation combined with task-specific therapy in people with spinal cord injury: a case study.
Chisholm AE, Malik RN, Blouin JS, et al. · J Neuroeng Rehabil · 2014Case Reports, Research Support, Non-U.S. Gov't
- Brain Vital Signs Detect Information Processing Differences When Neuromodulation Is Used During Cognitive Skills Training.
Smith CJ, Livingstone A, Fickling SD, et al. · Front Hum Neurosci · 2020
- Efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with acute mountain sickness: a study protocol for a double-blind, randomised, sham-controlled trial.
Tian YK, Wang X, Cao X, et al. · BMJ Open · 2026Clinical Trial Protocol
- The combined effect of cranial-nerve non-invasive neuromodulation with high-intensity physiotherapy on gait and balance in a patient with cerebellar degeneration: a case report.
Bastani A, Cofré Lizama LE, Zoghi M, et al. · Cerebellum Ataxias · 2018Case Reports
- Improvement in gait and functional abilities in an adult with posterior cortical atrophy after translingual neuromodulation with neurorehabilitation physical therapy: a case report.
Webeck JA, Laing K, Andrews DM · Physiother Theory Pract · 2025Case Reports
- Cortical surface morphometry changes following combined translingual neural stimulation with the portable neuromodulation stimulator and physical therapy in patients with mild-to-moderate traumatic brain injury: a pilot study.
Hou J, Hosseini T, Nair VA, et al. · Front Neurosci · 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.